pubmed.ncbi.nlm.nih.gov/42302979/ A new study by EGDRCs Guillermo E Umpierrez found no difference in kidney outcomes among GLP-1 drugs dulaglutide, exenatide, liraglutide, but semaglutide showed lower risk of death and combined kidney/death outcomes in adults with type 2 diabetes
Atherosclerosis 1992;96:33-42 32
The GLP-1 medications Mochi prescribes have clinical backing, but medication alone isnt everything
Genetic variation in GLP-1 receptor (GLP1R) and GIP receptor (GIPR) genes influences receptor sensitivity and gastric response
These factors may lead to synovial hyperplasia, pannus formation, bone erosion, and eventually irreversible deformities [1, 2]
Key Takeaway: While green tea is not a replacement for medical treatment, its natural polyphenols may help stimulate the release of GLP-1 and slow down its breakdown, supporting better appetite control